Centrally administered μ- and δ-opioid agonists increase operant responding for saccharin

Blake A. Gosnell, Chetan K. Patel

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

In previous reports, ICV administration of selective μ- or δ-opioid receptor agonists was found to stimulate the intake of saccharin and salt solutions in nondeprived rats. In the present study, we measured the effects of selective μ, δ, and κ-agonists on operant responding for saccharin. The selective μ-agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) and the selective δ-agonist [D-Thr2]-leucine enkephalin-Thr (DTLET) increased responding, whereas the κ-agonist dynorphin A analog κ ligand (DAKLI) had no significant effect. These results agree with previous studies on saccharin and salt intake and are consistent with the possibility that the effects of opioids on the intake of these fluids are mediated via enhancement of activity in brain reward pathways.

Original languageEnglish (US)
Pages (from-to)979-982
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Volume45
Issue number4
DOIs
StatePublished - Aug 1993

Keywords

  • Central injection
  • Operant
  • Opioid
  • Palatability
  • Reward
  • Saccharin
  • δ-Agonist
  • μ-Agonist

Fingerprint Dive into the research topics of 'Centrally administered μ- and δ-opioid agonists increase operant responding for saccharin'. Together they form a unique fingerprint.

Cite this